Novo Nordisk A/S NVO | NYSE
$38.86
-$0.36 | -0.92%
TREND SIGNAL:
|2026-08-04
|2026-08-04
Company Overview:
Market Cap:
$173.08B
Trailing PE:
—
FWD PE:
—
Payout Ratio (TTM):
44.6%
52-Week Range:
$35.12 - $64.16
10 Year NVO Performance Metrics:
Total Return (with DRIP):
174.0% (10.60% CAGR)
Total Return (no DRIP):
160.8% (10.06% CAGR)
Share Price:
92.7% (6.78% CAGR)
Yield on Cost (with DRIP):
8.16%
Total Invested:
$10,000
Total Value (with DRIP):
$27,398
Total Return $ (with DRIP):
$17,398
Dividend Increase:
74.6% (6.11% CAGR)
Dividend Yield (FWD):
2.98% ($1.16)
NVO 10-yr Total Return ($10K invested)
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
NVO Share Price
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
NVO Price CAGR:1Y: -30.72%2Y: -42.62%5Y: -5.36%10Y: 6.78%
NVO Dividend Charts
NVO Dividend CAGR:1Y: -0.62%2Y: -0.43%5Y: -0.16%10Y: 9.34%
NVO Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
NVO Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Unlock All Reports & Research Dividend Stocks like a BOSS!
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
NVO Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
NVO Revenue CAGR:1Y: 2.12%2Y: 7.39%5Y: 18.89%10Y: 11.07%
NVO EPS CAGR:1Y: -20.47%2Y: 2.75%5Y: 12.50%10Y: 1.92%
NVO Net Income CAGR:1Y: -20.81%2Y: 2.31%5Y: 11.60%10Y: 7.73%
NVO EBITDA CAGR:1Y: -11.28%2Y: 4.03%5Y: 19.31%10Y: 11.34%
NVO Free Cash Flow CAGR:1Y: 72.98%2Y: 6.67%5Y: 12.65%10Y: 12.78%
NVO Free Cash Flow / Share CAGR:1Y: 73.72%2Y: 7.02%5Y: 13.52%10Y: 6.66%
NVO Operating Income CAGR:1Y: -19.10%2Y: 2.96%5Y: 12.86%10Y: 8.03%
NVO Gross Profit CAGR:1Y: -4.10%2Y: 3.07%5Y: 17.43%10Y: 10.12%
NVO Shares Outstanding CAGR:1Y: -0.25%2Y: -0.33%5Y: -0.78%10Y: 5.73%
NVO Share Buybacks CAGR:1Y: 0.00%2Y: -31.46%5Y: -8.45%10Y: -0.31%
NVO Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
NVO Expenses CAGR:1Y: -21.35%2Y: -1.66%5Y: 46.70%10Y: 21.98%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
NVO Actual Revenue CAGR:1Y: 2.12%2Y: 7.39%5Y: 18.89%10Y: 11.07%
NVO Actual EPS CAGR:1Y: -20.47%2Y: 2.75%5Y: 12.50%10Y: 1.92%
NVO Actual Net Income CAGR:1Y: -20.81%2Y: 2.31%5Y: 11.60%10Y: 7.73%
NVO Actual EBITDA CAGR:1Y: -11.28%2Y: 4.03%5Y: 19.31%10Y: 11.34%
Ratios, Profit Margins & Return on Capital:
NVO Net Profit Margin CAGR:1Y: -22.45%2Y: -4.73%5Y: -6.13%10Y: -3.01%
NVO Gross Profit Margin CAGR:1Y: -6.10%2Y: -4.02%5Y: -1.23%10Y: -0.86%
NVO Price to Earnings CAGR:1Y: -10.02%2Y: -45.49%5Y: -7.82%10Y: 3.78%
NVO Price To Sales Ratio CAGR:1Y: -30.22%2Y: -48.06%5Y: -13.47%10Y: 0.65%
NVO Return on Capital Employed CAGR:1Y: -37.56%2Y: -27.05%5Y: -15.19%10Y: -11.81%
NVO Return on Invested Capital CAGR:1Y: -38.27%2Y: -28.28%5Y: -17.90%10Y: -13.10%
NVO Dividends Info:
Annual Dividend:
$1.158
Forward Yield:
2.98%
Ex-Dividend Date:
2026-08-17
Lifetime Dividends / Share:
$19.57
NVO Dividend History: Dates, Payments & Yield list
Below is a schedule of all NVO dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 08/17/2026 | 08/19/2026 | $0.579 | 2.58% | 2.49% | $46.48 |
| 03/30/2026 | 04/01/2026 | $1.275 | 7.23% | 6.99% | $36.48 |
| 09/18/2025 | 09/29/2025 | $0.004 | 0.01% | 0% | $0.00 |
| 08/18/2025 | 08/20/2025 | $0.584 | 2.17% | 2.15% | $54.30 |
| 03/31/2025 | 04/02/2025 | $1.099 | 3.17% | 3.22% | $68.24 |
| 08/16/2024 | 08/19/2024 | $0.513 | 0.76% | 0.76% | $135.25 |
| 03/22/2024 | 03/25/2024 | $0.930 | 1.44% | 1.44% | $129.05 |
| 08/18/2023 | 08/21/2023 | $0.221 | 0.48% | 0.48% | $92.93 |
| 03/24/2023 | 03/27/2023 | $0.594 | 1.56% | 1.54% | $77.35 |
| 08/12/2022 | 08/23/2022 | $0.584 | 2.17% | 2.19% | $53.29 |
| 03/25/2022 | 04/05/2022 | $1.036 | 3.89% | 3.61% | $57.40 |
| 08/16/2021 | 08/25/2021 | $0.557 | 2.16% | 2.15% | $51.81 |
| 03/26/2021 | 04/07/2021 | $0.949 | 5.6% | 5.59% | $33.95 |
| 08/14/2020 | 08/25/2020 | $0.518 | 3.15% | 3.12% | $33.23 |
| 03/27/2020 | 04/07/2020 | $0.783 | 5.52% | 5.35% | $29.27 |
| 08/16/2019 | 08/27/2019 | $0.449 | 3.48% | 3.44% | $26.08 |
| 03/22/2019 | 04/02/2019 | $0.789 | 6.22% | 6.06% | $26.05 |
| 08/17/2018 | 08/28/2018 | $0.467 | 1.97% | 1.88% | $24.83 |
| 03/23/2018 | 04/03/2018 | $0.670 | 2.76% | 2.73% | $24.57 |
| 08/17/2017 | 08/29/2017 | $0.474 | 2.09% | 2.04% | $23.25 |
| 03/23/2017 | 04/04/2017 | $0.663 | 4% | 3.68% | $18.02 |
| 08/11/2016 | 08/23/2016 | $0.447 | 1.92% | 1.89% | $23.71 |
| 03/18/2016 | 03/30/2016 | $0.964 | 3.53% | 3.55% | $27.13 |
| 03/19/2015 | 03/31/2015 | $0.760 | 3.15% | 2.85% | $26.70 |
| 03/21/2014 | 04/02/2014 | $0.830 | 3.78% | 3.65% | $22.76 |
| 03/21/2013 | 04/02/2013 | $0.637 | 3.95% | 3.88% | $16.43 |
| 03/22/2012 | 04/03/2012 | $0.499 | 3.52% | 3.34% | $14.93 |
| 03/24/2011 | 04/05/2011 | $0.364 | 2.95% | 2.85% | $12.76 |
| 03/08/2007 | 03/20/2007 | $0.122 | 2.9% | 2.79% | $4.36 |
| 04/23/1990 | 11/30/-0001 | $0.006 | 2.84% | 2.84% | $0.22 |
| 04/19/1991 | 11/30/-0001 | $0.005 | 1.59% | 1.59% | $0.32 |
| 04/28/1992 | 11/30/-0001 | $0.006 | 1.46% | 1.46% | $0.41 |
| 04/22/1993 | 11/30/-0001 | $0.005 | 1.2% | 1.2% | $0.45 |
| 04/22/1994 | 11/30/-0001 | $0.006 | 1.06% | 1.06% | $0.53 |
| 04/26/1994 | 11/30/-0001 | $0.006 | 1.04% | 1.04% | $0.54 |
| 04/21/1989 | 11/30/-0001 | $0.005 | 2.2% | 2.2% | $0.21 |
| 04/21/1988 | 11/30/-0001 | $0.005 | 3.73% | 3.73% | $0.14 |
| 04/20/1987 | 11/30/-0001 | $0.004 | 2.18% | 2.18% | $0.19 |
| 04/21/1986 | 11/30/-0001 | $0.003 | 2.02% | 2.02% | $0.17 |
| 04/19/1985 | 11/30/-0001 | $0.003 | 1.99% | 1.99% | $0.13 |
| 04/13/1984 | 11/30/-0001 | $0.003 | 2.4% | 2.4% | $0.24 |
| 04/13/1983 | 11/30/-0001 | $0.003 | 2.11% | 2.11% | $0.26 |
| 04/23/1982 | 11/30/-0001 | $0.001 | 0.57% | 0.57% | $0.21 |
| 04/24/1995 | 11/30/-0001 | $0.008 | 1.65% | 1.65% | $0.51 |
| 04/24/1996 | 11/30/-0001 | $0.007 | 1.11% | 1.11% | $0.65 |
| 05/01/1996 | 11/30/-0001 | $0.009 | 1.3% | 1.3% | $0.66 |
| 03/19/2009 | 11/30/-0001 | $0.207 | 4.49% | 4.49% | $4.61 |
| 03/13/2008 | 11/30/-0001 | $0.177 | 2.57% | 2.57% | $6.87 |
| 03/09/2006 | 11/30/-0001 | $0.097 | 3.3% | 3.3% | $2.93 |
| 03/10/2005 | 11/30/-0001 | $0.084 | 2.96% | 2.96% | $2.84 |
| 03/17/2004 | 11/30/-0001 | $0.075 | 3.24% | 3.24% | $2.30 |
| 03/26/2003 | 11/30/-0001 | $0.052 | 3.13% | 3.13% | $1.67 |
| 03/13/2002 | 11/30/-0001 | $0.037 | 1.93% | 1.93% | $1.91 |
| 03/21/2001 | 11/30/-0001 | $0.032 | 1.6% | 1.6% | $1.99 |
| 11/17/2000 | 11/30/-0001 | $0.019 | 1.03% | 1.03% | $1.82 |
| 03/24/2000 | 11/30/-0001 | $0.023 | 1.66% | 1.66% | $1.41 |
| 03/25/1999 | 11/30/-0001 | $0.016 | 1.64% | 1.64% | $1.00 |
| 03/27/1998 | 11/30/-0001 | $0.016 | 1.01% | 1.01% | $1.60 |
| 04/25/1997 | 11/30/-0001 | $0.011 | 1.11% | 1.11% | $1.01 |
| 03/25/2010 | 11/30/-0001 | $0.281 | 3.59% | 3.59% | $7.83 |
Projected Future Returns & Dividends for NVO
Based on past 10-year performance, here are NVO growth metrics:
Share price CAGR of +6.78%
Dividend CAGR of +6.11%
Using NVO CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| NVO (DRIP) | NVO - No DRIP | |
|---|---|---|
| Current Price | $38.86 | $38.86 |
| Start Shares | 257.33 | 257.33 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 343.09 | 257.33 |
| Dividends Payment | $1.05 | $1.05 |
| Annual Dividends | $719 | $539 |
| Yield on cost | 7.19% | 5.39% |
| Share Price | $74.87 | $74.87 |
| Total Dividends | $4,611 | $3,947 |
| Final Value | $25,686 | $23,213 |
Estimated Future Value + Dividends - NVO
NOTE: Above numbers are our estimate based on NVO's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Company Info
Novo Nordisk A/S (NVO) had its IPO on 1981-04-30, and is traded on NYSE stock exchange.
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
NVO website: https://www.novonordisk.com
Get Full Access to All Reports with DRIPCalc PRO
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Loading signals…
DCF Model — NVO
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $38.86
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
